GW870086X
Sponsors
GlaxoSmithKline
Conditions
Asthma
Phase 1
Examine the Effect of Repeat Inhaled Doses of GW870086X on Lung Function in Mild Asthmatic Male Subjects
CompletedNCT00483899
Start: 2005-10-07End: 2006-12-15Updated: 2017-09-29
A Randomized Study Evaluating Steroid Hormone Levels, Safety And Tolerability Of GW870086X In Healthy Volunteers
CompletedNCT00549497
Start: 2007-09-30End: 2008-01-31Updated: 2017-02-03
A Blinded, Dose Ascending Study to Assess the Pharmacokinetics, Safety and Tollerability of Repeat Inhaled Doses of Nebulised GW870086X in Healthy Adult Male Volunteers.
CompletedNCT01160003
Start: 2010-07-29End: 2010-11-05Updated: 2017-06-14
Phase 2
A Study to Evaluate the Effect of GW870086X on Allergen Challenge in Mild Asthmatics
CompletedNCT00857857
Start: 2009-02-16End: 2009-11-03Updated: 2018-02-20
A Study to Evaluate the Effect of Repeat Doses of GW870086X in Mild to Moderate Asthmatics
CompletedNCT00945932
Start: 2009-07-31End: 2009-12-31Updated: 2016-10-12